265 related articles for article (PubMed ID: 28647964)
1. [Association between single nucleotide polymorphism of BARD1 gene and BRCA1 gene mutation in epithelial ovarian cancer].
Liu WL; Zhao JZ; Wang ZZ; Dong B; Hou YY; Wu XX; Guo YJ
Zhonghua Fu Chan Ke Za Zhi; 2017 Jun; 52(6):403-410. PubMed ID: 28647964
[No Abstract] [Full Text] [Related]
2. [Association between single nucleotide polymorphisms of BARD 1 gene and susceptibility of early-onset breast cancer in Uygur women in Xinjiang].
Sun G; Wang JT; Ma BL; Geng ZL; Ren GH; Shan MH; Ma B; Ma LL; Wang Y
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):341-7. PubMed ID: 22883453
[TBL] [Abstract][Full Text] [Related]
3. Common non-synonymous polymorphisms in the BRCA1 Associated RING Domain (BARD1) gene are associated with breast cancer susceptibility: a case-control analysis.
Huo X; Hu Z; Zhai X; Wang Y; Wang S; Wang X; Qin J; Chen W; Jin G; Liu J; Gao J; Wei Q; Wang X; Shen H
Breast Cancer Res Treat; 2007 May; 102(3):329-37. PubMed ID: 17028982
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance and distribution of BRCA genes mutation in sporadic high grade serous ovarian cancer].
Liu WL; Wang ZZ; Zhao JZ; Hou YY; Wu XX; Li W; Dong B; Tong TT; Guo YJ
Zhonghua Fu Chan Ke Za Zhi; 2017 Jan; 52(1):26-31. PubMed ID: 28190312
[No Abstract] [Full Text] [Related]
5. BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition.
Vahteristo P; Syrjäkoski K; Heikkinen T; Eerola H; Aittomäki K; von Smitten K; Holli K; Blomqvist C; Kallioniemi OP; Nevanlinna H
Eur J Hum Genet; 2006 Feb; 14(2):167-72. PubMed ID: 16333312
[TBL] [Abstract][Full Text] [Related]
6. Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.
Ramus SJ; Song H; Dicks E; Tyrer JP; Rosenthal AN; Intermaggio MP; Fraser L; Gentry-Maharaj A; Hayward J; Philpott S; Anderson C; Edlund CK; Conti D; Harrington P; Barrowdale D; Bowtell DD; Alsop K; Mitchell G; ; Cicek MS; Cunningham JM; Fridley BL; Alsop J; Jimenez-Linan M; Poblete S; Lele S; Sucheston-Campbell L; Moysich KB; Sieh W; McGuire V; Lester J; Bogdanova N; Dürst M; Hillemanns P; ; Odunsi K; Whittemore AS; Karlan BY; Dörk T; Goode EL; Menon U; Jacobs IJ; Antoniou AC; Pharoah PD; Gayther SA
J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26315354
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in HPV E6/E7 protein interacted genes and risk of cervical cancer in Chinese women: a case-control analysis.
Zhou X; Han S; Wang S; Chen X; Dong J; Shi X; Xia Y; Wang X; Hu Z; Shen H
Gynecol Oncol; 2009 Aug; 114(2):327-31. PubMed ID: 19482343
[TBL] [Abstract][Full Text] [Related]
8. Association of three common BARD1 variants with cancer susceptibility: a system review and meta-analysis.
Liu X; Zhang X; Chen Y; Yang X; Xing Y; Ma L
Int J Clin Exp Med; 2015; 8(1):311-21. PubMed ID: 25785002
[TBL] [Abstract][Full Text] [Related]
9. The BARD1 Cys557Ser variant and breast cancer risk in Iceland.
Stacey SN; Sulem P; Johannsson OT; Helgason A; Gudmundsson J; Kostic JP; Kristjansson K; Jonsdottir T; Sigurdsson H; Hrafnkelsson J; Johannsson J; Sveinsson T; Myrdal G; Grimsson HN; Bergthorsson JT; Amundadottir LT; Gulcher JR; Thorsteinsdottir U; Kong A; Stefansson K
PLoS Med; 2006 Jul; 3(7):e217. PubMed ID: 16768547
[TBL] [Abstract][Full Text] [Related]
10. Germline BRCA1/2 mutation testing is indicated in every patient with epithelial ovarian cancer: A systematic review.
Arts-de Jong M; de Bock GH; van Asperen CJ; Mourits MJ; de Hullu JA; Kets CM
Eur J Cancer; 2016 Jul; 61():137-45. PubMed ID: 27209246
[TBL] [Abstract][Full Text] [Related]
11. Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer.
Weber-Lassalle N; Borde J; Weber-Lassalle K; Horváth J; Niederacher D; Arnold N; Kaulfuß S; Ernst C; Paul VG; Honisch E; Klaschik K; Volk AE; Kubisch C; Rapp S; Lichey N; Altmüller J; Lepkes L; Pohl-Rescigno E; Thiele H; Nürnberg P; Larsen M; Richters L; Rhiem K; Wappenschmidt B; Engel C; Meindl A; Schmutzler RK; Hahnen E; Hauke J
Breast Cancer Res; 2019 Apr; 21(1):55. PubMed ID: 31036035
[TBL] [Abstract][Full Text] [Related]
12. Variant Identification in BARD1, PRDM9, RCC1, and RECQL in Patients with Ovarian Cancer by Targeted Next-generation Sequencing of DNA Pools.
Suszynska M; Ratajska M; Galka-Marciniak P; Ryszkowska A; Wydra D; Debniak J; Jasiak A; Wasag B; Cybulski C; Kozlowski P
Cancer Prev Res (Phila); 2022 Mar; 15(3):151-160. PubMed ID: 34906988
[TBL] [Abstract][Full Text] [Related]
13. Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers.
Spurdle AB; Marquart L; McGuffog L; Healey S; Sinilnikova O; Wan F; Chen X; Beesley J; Singer CF; Dressler AC; Gschwantler-Kaulich D; Blum JL; Tung N; Weitzel J; Lynch H; Garber J; Easton DF; Peock S; Cook M; Oliver CT; Frost D; Conroy D; Evans DG; Lalloo F; Eeles R; Izatt L; Davidson R; Chu C; Eccles D; Selkirk CG; Daly M; Isaacs C; Stoppa-Lyonnet D; Sinilnikova OM; Buecher B; Belotti M; Mazoyer S; Barjhoux L; Verny-Pierre C; Lasset C; Dreyfus H; Pujol P; Collonge-Rame MA; ; Rookus MA; Verhoef S; Kriege M; Hoogerbrugge N; Ausems MG; van Os TA; Wijnen J; Devilee P; Meijers-Heijboer HE; Blok MJ; Heikkinen T; Nevanlinna H; Jakubowska A; Lubinski J; Huzarski T; Byrski T; Durocher F; Couch FJ; Lindor NM; Wang X; Thomassen M; Domchek S; Nathanson K; Caligo M; Jernström H; Liljegren A; Ehrencrona H; Karlsson P; ; Ganz PA; Olopade OI; Tomlinson G; Neuhausen S; Antoniou AC; Chenevix-Trench G; Rebbeck TR
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):1032-8. PubMed ID: 21393566
[TBL] [Abstract][Full Text] [Related]
14. Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.
Rebbeck TR; Mitra N; Domchek SM; Wan F; Chuai S; Friebel TM; Panossian S; Spurdle A; Chenevix-Trench G; ; Singer CF; Pfeiler G; Neuhausen SL; Lynch HT; Garber JE; Weitzel JN; Isaacs C; Couch F; Narod SA; Rubinstein WS; Tomlinson GE; Ganz PA; Olopade OI; Tung N; Blum JL; Greenberg R; Nathanson KL; Daly MB
Cancer Res; 2009 Jul; 69(14):5801-10. PubMed ID: 19584272
[TBL] [Abstract][Full Text] [Related]
15. Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
Kuchenbaecker KB; Ramus SJ; Tyrer J; Lee A; Shen HC; Beesley J; Lawrenson K; McGuffog L; Healey S; Lee JM; Spindler TJ; Lin YG; Pejovic T; Bean Y; Li Q; Coetzee S; Hazelett D; Miron A; Southey M; Terry MB; Goldgar DE; Buys SS; Janavicius R; Dorfling CM; van Rensburg EJ; Neuhausen SL; Ding YC; Hansen TV; Jønson L; Gerdes AM; Ejlertsen B; Barrowdale D; Dennis J; Benitez J; Osorio A; Garcia MJ; Komenaka I; Weitzel JN; Ganschow P; Peterlongo P; Bernard L; Viel A; Bonanni B; Peissel B; Manoukian S; Radice P; Papi L; Ottini L; Fostira F; Konstantopoulou I; Garber J; Frost D; Perkins J; Platte R; Ellis S; ; Godwin AK; Schmutzler RK; Meindl A; Engel C; Sutter C; Sinilnikova OM; ; Damiola F; Mazoyer S; Stoppa-Lyonnet D; Claes K; De Leeneer K; Kirk J; Rodriguez GC; Piedmonte M; O'Malley DM; de la Hoya M; Caldes T; Aittomäki K; Nevanlinna H; Collée JM; Rookus MA; Oosterwijk JC; ; Tihomirova L; Tung N; Hamann U; Isaccs C; Tischkowitz M; Imyanitov EN; Caligo MA; Campbell IG; Hogervorst FB; ; Olah E; Diez O; Blanco I; Brunet J; Lazaro C; Pujana MA; Jakubowska A; Gronwald J; Lubinski J; Sukiennicki G; Barkardottir RB; Plante M; Simard J; Soucy P; Montagna M; Tognazzo S; Teixeira MR; ; Pankratz VS; Wang X; Lindor N; Szabo CI; Kauff N; Vijai J; Aghajanian CA; Pfeiler G; Berger A; Singer CF; Tea MK; Phelan CM; Greene MH; Mai PL; Rennert G; Mulligan AM; Tchatchou S; Andrulis IL; Glendon G; Toland AE; Jensen UB; Kruse TA; Thomassen M; Bojesen A; Zidan J; Friedman E; Laitman Y; Soller M; Liljegren A; Arver B; Einbeigi Z; Stenmark-Askmalm M; Olopade OI; Nussbaum RL; Rebbeck TR; Nathanson KL; Domchek SM; Lu KH; Karlan BY; Walsh C; Lester J; ; ; Hein A; Ekici AB; Beckmann MW; Fasching PA; Lambrechts D; Van Nieuwenhuysen E; Vergote I; Lambrechts S; Dicks E; Doherty JA; Wicklund KG; Rossing MA; Rudolph A; Chang-Claude J; Wang-Gohrke S; Eilber U; Moysich KB; Odunsi K; Sucheston L; Lele S; Wilkens LR; Goodman MT; Thompson PJ; Shvetsov YB; Runnebaum IB; Dürst M; Hillemanns P; Dörk T; Antonenkova N; Bogdanova N; Leminen A; Pelttari LM; Butzow R; Modugno F; Kelley JL; Edwards RP; Ness RB; du Bois A; Heitz F; Schwaab I; Harter P; Matsuo K; Hosono S; Orsulic S; Jensen A; Kjaer SK; Hogdall E; Hasmad HN; Azmi MA; Teo SH; Woo YL; Fridley BL; Goode EL; Cunningham JM; Vierkant RA; Bruinsma F; Giles GG; Liang D; Hildebrandt MA; Wu X; Levine DA; Bisogna M; Berchuck A; Iversen ES; Schildkraut JM; Concannon P; Weber RP; Cramer DW; Terry KL; Poole EM; Tworoger SS; Bandera EV; Orlow I; Olson SH; Krakstad C; Salvesen HB; Tangen IL; Bjorge L; van Altena AM; Aben KK; Kiemeney LA; Massuger LF; Kellar M; Brooks-Wilson A; Kelemen LE; Cook LS; Le ND; Cybulski C; Yang H; Lissowska J; Brinton LA; Wentzensen N; Hogdall C; Lundvall L; Nedergaard L; Baker H; Song H; Eccles D; McNeish I; Paul J; Carty K; Siddiqui N; Glasspool R; Whittemore AS; Rothstein JH; McGuire V; Sieh W; Ji BT; Zheng W; Shu XO; Gao YT; Rosen B; Risch HA; McLaughlin JR; Narod SA; Monteiro AN; Chen A; Lin HY; Permuth-Wey J; Sellers TA; Tsai YY; Chen Z; Ziogas A; Anton-Culver H; Gentry-Maharaj A; Menon U; Harrington P; Lee AW; Wu AH; Pearce CL; Coetzee G; Pike MC; Dansonka-Mieszkowska A; Timorek A; Rzepecka IK; Kupryjanczyk J; Freedman M; Noushmehr H; Easton DF; Offit K; Couch FJ; Gayther S; Pharoah PP; Antoniou AC; Chenevix-Trench G;
Nat Genet; 2015 Feb; 47(2):164-71. PubMed ID: 25581431
[TBL] [Abstract][Full Text] [Related]
16. Enhancing the BOADICEA cancer risk prediction model to incorporate new data on
Lee A; Mavaddat N; Cunningham A; Carver T; Ficorella L; Archer S; Walter FM; Tischkowitz M; Roberts J; Usher-Smith J; Simard J; Schmidt MK; Devilee P; Zadnik V; Jürgens H; Mouret-Fourme E; De Pauw A; Rookus M; Mooij TM; Pharoah PP; Easton DF; Antoniou AC
J Med Genet; 2022 Dec; 59(12):1206-1218. PubMed ID: 36162851
[TBL] [Abstract][Full Text] [Related]
17. BRCA1/2 mutations and expression: response to platinum chemotherapy in patients with advanced stage epithelial ovarian cancer.
Dann RB; DeLoia JA; Timms KM; Zorn KK; Potter J; Flake DD; Lanchbury JS; Krivak TC
Gynecol Oncol; 2012 Jun; 125(3):677-82. PubMed ID: 22406760
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of missense alterations in the BRCA1 associated RING domain (BARD1) gene in breast and ovarian cancer.
Sauer MK; Andrulis IL
J Med Genet; 2005 Aug; 42(8):633-8. PubMed ID: 16061562
[TBL] [Abstract][Full Text] [Related]
19. The Effects of Genetic and Epigenetic Alterations of BARD1 on the Development of Non-Breast and Non-Gynecological Cancers.
Watters AK; Seltzer ES; MacKenzie D; Young M; Muratori J; Hussein R; Sodoma AM; To J; Singh M; Zhang D
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32708251
[TBL] [Abstract][Full Text] [Related]
20. Mutations in exon region of BRCA1-related RING domain 1 gene and risk of breast cancer.
Wu J; Aini A; Ma B
Mol Genet Genomic Med; 2022 Mar; 10(3):e1847. PubMed ID: 35084806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
